Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
1.220
+0.050 (4.27%)
At close: Oct 23, 2026, 4:00 PM EDT
1.250
+0.030 (2.46%)
After-hours: Oct 23, 2026, 6:13 PM EDT
Cellectar Biosciences Market Cap
Cellectar Biosciences has a market cap or net worth of $11.53 million as of October 23, 2026. It is the 40,595th most valuable company in the world and the 5,516th biggest in the United States. Its market cap has decreased by 7.75% in one year.
Market Cap
11.53M
Enterprise Value
-20.93M
1-Year Change
-7.75%
Global Rank
Country Rank
#5,516 United States
Category
ChartMarket Cap Chart
Since August 15, 2014, Cellectar Biosciences's market cap has increased from $9.20M to $11.53M, an increase of 25.34%. That is a compound annual growth rate of 1.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 11.50M | -8.00% |
| Dec 31, 2025 | 12.50M | 1.63% |
| Dec 31, 2024 | 12.30M | -63.82% |
| Dec 29, 2023 | 34.00M | 112.50% |
| Dec 30, 2022 | 16.00M | -60.59% |
| Dec 31, 2021 | 40.60M | -27.24% |
| Dec 31, 2020 | 55.80M | 164.45% |
| Dec 31, 2019 | 21.10M | 185.14% |
| Dec 31, 2018 | 7.40M | -65.90% |
| Dec 29, 2017 | 21.70M | 233.85% |
| Dec 30, 2016 | 6.50M | 3.17% |
| Dec 31, 2015 | 6.30M | -73.08% |
| Dec 31, 2014 | 23.40M | 154.35% |
| Aug 15, 2014 | 9.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cerenome | 12.45M |
| Pluri | 12.22M |
| Bolt Biotherapeutics | 12.08M |
| AEON Biopharma | 11.97M |
| Lipocine | 11.87M |
| Karyopharm Therapeutics | 11.74M |
| Actuate Therapeutics | 11.41M |
| Citius Pharmaceuticals | 11.07M |